Rachel L. Epstein, MD, MScE
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Infectious Diseases

MD, Thomas Jefferson University
MSc, Boston University School of Public Health
MA, Wesleyan University

Pronouns: she/her/hers



Rachel L. Epstein, MD, MScE, is a clinician-scientist working to utilize large data sets and decision modelling to inform policy and program design to improve care for individuals with Hepatitis C, HIV, and substance use, with a particular focus on pregnant women and youth.

Dr. Epstein completed combined residency training in internal medicine-pediatrics at Brown University, and worked in primary care through the Providence Community Health Centers and the Hasbro Adolescent Center before fellowship. She completed a combined adult and pediatric infectious diseases fellowship at Boston Medical Center and a T32 post-doctoral research fellowship through the Boston University Clinical HIV/AIDS Research Training Program (BU-CHART). She is an Assistant Professor in the BUSM Department of Medicine, Section of Infectious Diseases, and Department of Pediatrics, Section of Infectious Diseases and sees adult and pediatric patients living with or at risk for Hepatitis C virus, HIV, and other infectious diseases. She also serves as the Med-Peds faculty specific advisor lead for BUSM students. Her current and recent work includes projects analyzing the effects of Medicaid HCV treatment restrictions on care cascade outcome achievement, HIV prevention and medication adherence, and comparing the cost-effectiveness of various HCV and screening, evaluation, and treatment interventions.



Postdoctoral Research Fellowship Program
12/01/2020 - 11/30/2022 (PI)
Charles A. King Trust

Medicaid State Hepatitis C Treatment Restrictions: Spillover Effects on the Care Cascade
05/01/2019 - 04/30/2020 (PI)
Weill Cornell Medical College NIH-NIDA


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Epstein RL, Espinosa C. Hepatitis C Virus in Neonates and Infants. Clin Perinatol. 2021 06; 48(2):343-357. PMID: 34030818
     
  2. Epstein RL, Sperring H, Hofman M, Lodi S, White LF, Barocas JA, Bouton TC, Xiao Y, Hsu HE, Miller NS, Linas BP, Marathe JG. Time to SARS-CoV-2 PCR Clearance in Immunocompromising Conditions: Is Test-Based Removal From Isolation Necessary in Severely Immunocompromised Individuals? Open Forum Infect Dis. 2021 Jun; 8(6):ofab164.View Related Profiles. PMID: 34189164; PMCID: PMC8231388; DOI: 10.1093/ofid/ofab164;
     
  3. Epstein RL, Penwill N, Clarke DF, Hamilton S, Horbowicz K, Dorfman D, Moses JM, Cooper ER. "Meds-in-Hand" Intervention to Reduce Critical Process Delays in Pediatric Human Immunodeficiency Virus Post-Exposure Prophylaxis. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):196-200.View Related Profiles. PMID: 32347312; PMCID: PMC7996639; DOI: 10.1093/jpids/piaa033;
     
  4. Linas BP, Savinkina A, Madushani RWMA, Wang J, Eftekhari Yazdi G, Chatterjee A, Walley AY, Morgan JR, Epstein RL, Assoumou SA, Murphy SM, Schackman BR, Chrysanthopoulou SA, White LF, Barocas JA. Projected Estimates of Opioid Mortality After Community-Level Interventions. JAMA Netw Open. 2021 02 01; 4(2):e2037259.View Related Profiles. PMID: 33587136; PMCID: PMC7885041; DOI: 10.1001/jamanetworkopen.2020.37259;
     
  5. Morgan JR, Barocas JA, Murphy SM, Epstein RL, Stein MD, Schackman BR, Walley AY, Linas BP. Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting. JAMA Netw Open. 2020 12 01; 3(12):e2029676.View Related Profiles. PMID: 33320266; PMCID: PMC7739119; DOI: 10.1001/jamanetworkopen.2020.29676;
     
  6. Epstein RL, Wang J, Hagan L, Mayer KH, Puro J, Linas BP, Assoumou SA. Hepatitis C Virus Antibody Testing Among 13- to 21-Year-Olds in a Large Sample of US Federally Qualified Health Centers. JAMA. 2019 12 10; 322(22):2245-2248.View Related Profiles. PMID: 31821424; PMCID: PMC7081751; DOI: 10.1001/jama.2019.16196;
     
  7. Epstein RL, Bhagavathula M, Saag LA, Verma S, Kan CK, Mesick J, Kamineni P, White LF, Barnett ED, Salgame P, Hochberg NS. QuantiFERON®-TB Gold In-Tube reliability for immigrants with parasitic infections in Boston, USA. Int J Tuberc Lung Dis. 2019 04 01; 23(4):482-490.View Related Profiles. PMID: 31064628; PMCID: PMC6690781; DOI: 10.5588/ijtld.18.0540;
     
  8. Tasillo A, Eftekhari Yazdi G, Nolen S, Schillie S, Vellozzi C, Epstein R, Randall L, Salomon JA, Linas BP. Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal Care. Obstet Gynecol. 2019 02; 133(2):289-300.View Related Profiles. PMID: 30633134; PMCID: PMC6501827; DOI: 10.1097/AOG.0000000000003062;
     
  9. Epstein RL, Sabharwal V, Wachman EM, Saia KA, Vellozzi C, Hariri S, Linas BP. Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care. J Pediatr. 2018 12; 203:34-40.e1.View Related Profiles. PMID: 30170857; PMCID: PMC6252153; DOI: 10.1016/j.jpeds.2018.07.006;
     
  10. Epstein R, Ristau J, Ellner JJ. An Unsuspected Zoonotic Infection Presenting as Sepsis. Am J Med. 2018 Jan; 131(1):e17-e18.View Related Profiles. PMID: 28860034
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 10 publications over 5 distinct years, with a maximum of 4 publications in 2021

YearPublications
20171
20181
20193
20201
20214
Contact for Mentoring:
Epstein's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department